Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition

Figure 1

Study design and plasma liraglutide levels. (A) Study outline/liraglutide dosage regimen, mo = months of age, GTT = glucose tolerance testing including mixed meal glucose tolerance test (MMGTT) and intravenous glucose tolerance test (IVGTT). (B) Plasma liraglutide levels at the end of the treatment period in non-fasted GIPRdn transgenic pigs after 1.2 mg liraglutide injection; 0 hours = point of liraglutide administration.

Back to article page